Form 8-K - Current report:
SEC Accession No. 0000875045-20-000032
Filing Date
2020-10-21
Accepted
2020-10-21 07:21:59
Documents
16
Period of Report
2020-10-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K biib-20201021.htm   iXBRL 8-K 38136
2 EX-99.1 exhibit991-q32020press.htm EX-99.1 614901
8 biogenlogostandarda2911.jpg GRAPHIC 756402
  Complete submission text file 0000875045-20-000032.txt   1856936

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT biib-20201021.xsd EX-101.SCH 2443
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT biib-20201021_cal.xml EX-101.CAL 726
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT biib-20201021_def.xml EX-101.DEF 1663
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT biib-20201021_lab.xml EX-101.LAB 24275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT biib-20201021_pre.xml EX-101.PRE 12662
9 EXTRACTED XBRL INSTANCE DOCUMENT biib-20201021_htm.xml XML 11365
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 201249613
SIC: 2836 Biological Products, (No Diagnostic Substances)